Phibro Animal Health Corporation Class A Common Stock (PAHC) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 26	$0.73	$0.85	+16.4%	—	$396.7M	—
Q3 26	$0.71	$0.76	+7.0%	—	$383.5M	—
Q2 26	$0.67	$0.87	+29.9%	—	$373.9M	—
Q1 26	$0.6	$0.73	+21.7%	—	$363.9M	—
Q4 25	$0.52	$0.57	+9.6%	—	$378.7M	—
Q3 25	$0.52	$0.63	+21.2%	—	$347.8M	—
Q2 25	$0.45	$0.54	+20.0%	—	$309.3M	—
Q1 25	$0.25	$0.35	+40.0%	—	$260.4M	—
Q4 24	$0.33	$0.41	+24.2%	—	$273.2M	—
Q3 24	$0.29	$0.31	+6.9%	—	$263.2M	—
Q2 24	$0.28	$0.33	+17.9%	—	$249.9M	—
Q1 24	$0.23	$0.14	-39.1%	—	$231.3M	—
Q4 23	$0.38	$0.38	0.0%	—	$255M	—
Q3 23	$0.34	$0.29	-14.7%	—	$245.7M	—
Q2 23	$0.3	$0.34	+13.3%	—	$244.6M	—
Q1 23	$0.27	$0.21	-22.2%	—	$232.5M	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$2.46	—	—	$1.5B	—
FY25	—	$1.19	—	—	$1.3B	—
FY24	—	$0.06	—	—	$1B	—
FY23	—	$0.81	—	—	$977.9M

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$764.3M	$820M	$828M	$800.4M	$833.4M	$942.3M	$977.9M	$1B	$1.3B	$1.5B
YoY change	+1.7%	+7.29%	+0.98%	-3.34%	+4.12%	+13.1%	+3.78%	+4.07%	+27.4%	+17.1%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	764.3M	820M	828M	800.4M	833.4M	942.3M	977.9M	1B	1.3B	1.5B
Cost of revenue	516M	553.1M	563.4M	543.5M	562M	656.9M	679.7M	704.6M	896.3M	1B
Gross profit	248.2M	266.9M	264.6M	256.9M	271.4M	285.4M	298.2M	313.1M	399.9M	512.5M
Gross margin	32.5%	32.5%	32%	32.1%	32.6%	30.3%	30.5%	30.8%	30.9%	33.8%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	150.3M	168M	181.4M	187.7M	196.5M	206.4M	226.4M	259.8M	289.5M	318.1M
Operating expenses	150.3M	168M	181.4M	187.7M	196.5M	206.4M	226.4M	259.8M	289.5M	318.1M
Operating income	97.9M	98.9M	83.2M	69.2M	74.9M	79M	71.8M	53.3M	110.5M	194.4M
Operating margin	12.8%	12.1%	10.1%	8.65%	8.98%	8.38%	7.35%	5.24%	8.52%	12.8%
Non-operating income, net	-2.5M	1.1M	55K	-826K	4.5M	5.2M	-2.5M	-23.9M	-7.9M	-12.6M
Pretax income	80.5M	88.1M	71.5M	55.5M	66.5M	72.3M	54.1M	10.9M	68M	137.3M
Income tax	15.9M	23.2M	16.8M	22M	12.1M	23.2M	21.5M	8.5M	19.7M	37.6M
Net income	64.6M	64.9M	54.7M	33.6M	54.4M	49.2M	32.6M	2.4M	48.3M	99.7M
Net margin	8.45%	7.91%	6.61%	4.19%	6.53%	5.22%	3.33%	0.24%	3.72%	6.57%
EBITDA	125.9M	126.7M	112.7M	102.4M	105.7M	111.9M	108.5M	92.9M	154.7M	245.6M
EPS	1.63	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.46
Diluted EPS	1.61	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.43

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	231.3M	249.9M	263.2M	273.2M	260.4M	309.3M	347.8M	378.7M	363.9M	373.9M	383.5M	396.7M
Cost of revenue	163.6M	171.3M	183.6M	186M	176.9M	207.4M	243.3M	268.7M	244.1M	241.3M	257.9M	262.3M
Gross profit	67.7M	78.6M	79.6M	87.2M	83.5M	101.9M	104.6M	110M	119.8M	132.7M	125.7M	134.4M
Gross margin	29.3%	31.5%	30.2%	31.9%	32.1%	32.9%	30.1%	29%	32.9%	35.5%	32.8%	33.9%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	68.5M	62.9M	59.7M	68.7M	65.8M	76.3M	71.1M	76.3M	68.5M	82.3M	81M	86.2M
Operating expenses	68.5M	62.9M	59.7M	68.7M	65.8M	76.3M	71.1M	76.3M	68.5M	82.3M	81M	86.2M
Operating income	-726K	15.7M	19.9M	18.4M	17.7M	25.5M	33.5M	33.7M	51.3M	50.3M	44.7M	48.2M
Operating margin	-0.31%	6.28%	7.57%	6.74%	6.8%	8.26%	9.64%	8.9%	14.1%	13.5%	11.6%	12.1%
Non-operating income, net	-6.7M	-7.5M	-2.4M	-7.3M	-438K	-11.7M	5.5M	-1.3M	-2.9M	-2.1M	-1.9M	-5.6M
Pretax income	-12M	3.6M	12.9M	6.4M	9.6M	4.8M	29.7M	23.8M	36.3M	36.4M	32.3M	32.3M
Income tax	-4M	2.3M	4.5M	5.7M	2.6M	1.7M	8.8M	6.6M	9.7M	9M	8.3M	10.6M
Net income	-8M	1.3M	8.4M	752K	7M	3.2M	20.9M	17.2M	26.5M	27.5M	24M	21.7M
Net margin	-3.46%	0.51%	3.19%	0.28%	2.68%	1.03%	6%	4.55%	7.29%	7.34%	6.26%	5.47%
EBITDA	8.9M	25.4M	29.9M	28.6M	27.2M	37.3M	45.9M	46M	64M	63.3M	56.8M	61.4M
EPS	-0.2	0.03	0.21	—	0.17	0.08	0.52	0.42	0.65	0.68	0.59	0.54
Diluted EPS	-0.2	0.03	0.21	—	0.17	0.08	0.51	0.42	0.65	0.67	0.59	0.53

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	1.5B	1.9B	1.3B	1.1B	1.2B	774.8M	554.9M	679.3M	1B	1.3B	1.4B
Enterprise value	1.7B	2.1B	1.5B	1.4B	1.5B	1.2B	983.6M	1.1B	1.7B	2B	2.1B
Shares outstanding	39.5M	40.2M	40.4M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M	40.5M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	22.6	28.5	23.5	31.7	21.5	15.8	17	281.1	21.4	12.8	14.2
P/S	1.91	2.26	1.55	1.33	1.4	0.82	0.57	0.67	0.8	0.84	0.92
P/B	9.68	10	5.94	5.65	4.9	2.95	1.96	2.65	3.62	3.3	3.63
EV/EBITDA	13.7	16.5	13.6	13.5	14.2	10.3	9.07	11.7	11.1	8.06	8.64
EV/Sales	2.25	2.54	1.85	1.73	1.8	1.22	1.01	1.07	1.33	1.3	1.39
Earnings yield	4.42%	3.5%	4.26%	3.15%	4.65%	6.35%	5.88%	0.36%	4.67%	7.83%	7.05%
FCF yield	5.3%	2.78%	1.35%	2.38%	1.62%	-0.7%	-6.94%	6.82%	4.04%	0.77%	-1.33%
PEG	—	—	—	—	—	—	—	—	—	—	0.5

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	32.5%	32.5%	32%	32.1%	32.6%	30.3%	30.5%	30.8%	30.9%	33.8%	33.9%
Operating margin	12.8%	12.1%	10.1%	8.65%	8.98%	8.38%	7.35%	5.24%	8.52%	12.8%	10.6%
Net margin	8.45%	7.91%	6.61%	4.19%	6.53%	5.22%	3.33%	0.24%	3.72%	6.57%	6.57%
ROE	42.7%	35.1%	25.3%	17.8%	22.8%	18.7%	11.5%	0.94%	16.9%	25.9%	29.7%
ROA	10.4%	9.66%	7.53%	4.28%	6.46%	5.28%	3.36%	0.25%	3.55%	6.64%	8.48%
ROIC	19.2%	17.4%	13.8%	8.24%	10.7%	8.37%	6.09%	1.77%	8.08%	12.9%	12.9%
Return on tangible assets	13.9%	12.6%	9.48%	6.25%	8.9%	7.05%	4.32%	0.31%	4.13%	7.55%	7.55%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	3.14	2.9	3.02	2.87	3.04	2.97	3.33	2.94	2.76	2.96	2.96
Quick ratio	1.75	1.66	1.74	1.62	1.72	1.61	1.75	1.64	1.25	1.27	1.27
Debt / equity	2.07	1.69	1.51	2.18	1.79	1.79	1.81	2.05	2.67	2.05	2.06
Debt / assets	0.5	0.47	0.45	0.52	0.51	0.5	0.52	0.53	0.56	0.53	0.53
Net debt / EBITDA	2.04	1.84	2.17	3.12	3.15	3.39	3.95	4.42	4.42	2.88	2.88
Interest coverage	5.77	7.92	6.23	5.04	6.6	6.98	4.01	1.5	3.04	4.11	4.12
Effective tax rate	19.8%	26.3%	23.5%	39.6%	18.2%	32%	39.7%	77.9%	29%	27.4%	27.4%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	19.3	20.4	20.5	19.8	20.6	23.3	24.1	25.1	32	37.4	37.4
EPS (basic)	1.63	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.46	2.46
EPS (diluted)	1.61	1.61	1.35	0.83	1.34	1.21	0.81	0.06	1.19	2.43	2.43
Book value per share	3.83	4.6	5.35	4.65	5.89	6.48	6.97	6.34	7.05	9.51	9.5
FCF per share	1.96	1.28	0.43	0.62	0.47	-0.13	-0.95	1.14	1.03	0.24	0.24
Cash per share	1.42	1.97	2.02	2.26	2.3	2.25	2.01	2.83	1.9	2.02	2.07
Capex per share	—	—	—	—	—	—	—	—	0.95	1.46	1.44

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	—	—	—	—	—	—	—	—	2.95%	3.89%	3.89%
Capex / operating cash flow	—	—	—	—	—	—	—	—	47.8%	85.7%	85.7%
Payout ratio	24.5%	24.8%	34%	57.9%	35.7%	39.5%	59.6%	804.7%	40.3%	19.5%	19.8%
Dividend yield	1.08%	0.87%	1.45%	1.83%	1.66%	2.51%	3.5%	2.86%	1.88%	1.53%	1.34%

Yield

1.34%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.12

ex-dividend Sep 2, 2026

Payout ratio

20%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Sep 2, 2026	$0.12
Jun 3, 2026	$0.12
Mar 4, 2026	$0.12
Nov 26, 2025	$0.12
Sep 3, 2025	$0.12
Jun 4, 2025

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	$231.3M	$249.9M	$263.2M	$273.2M	$260.4M	$309.3M	$347.8M	$378.7M	$363.9M	$373.9M	$383.5M	$396.7M
YoY change	-0.5%	+2.17%	+7.14%	+7.1%	+12.6%	+23.7%	+32.1%	+38.6%	+39.7%	+20.9%	+10.3%	+4.77%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	56.1M	79.2M	81.6M	91.3M	93.2M	91.2M	81.3M	114.6M	77M	82M
Receivables	125.8M	135.7M	159M	126.5M	146.9M	166.5M	163.5M	169.5M	228M	238.8M
Inventory	161.2M	178.2M	198.3M	196.7M	216.3M	259.2M	277.6M	265.9M	444.4M	534.9M
Total current assets	363.7M	415.5M	466.2M	451.8M	498.9M	566.2M	585.7M	601M	810.6M	935.5M
Property, plant & equipment	61.4M	61.3M	69.2M	101.5M	107.3M	113.6M	126.1M	120.7M	220.1M	224.6M
Goodwill & intangibles	157.2M	158.7M	149.7M	247.4M	229.9M	234.2M	216.5M	199.2M	192.2M	180.2M
Total assets	623.4M	671.7M	726.7M	784.1M	841.3M	931.7M	971.4M	982.2M	1.4B	1.5B
Accounts payable	56.9M	59.5M	73.2M	66.1M	68.4M	95.6M	73.9M	85.6M	138.2M	127.3M
Short-term debt	6.3M	12.6M	12.5M	25.2M	16M	21.1M	28.3M	37.3M	25.4M	35.6M
Total current liabilities	115.8M	143.2M	154.2M	157.2M	164.1M	190.8M	176M	204.1M	293.5M	316.5M
Long-term debt	306.9M	299.8M	313.6M	385.5M	410.7M	449.4M	481.6M	488.2M	736.2M	753.2M
Total liabilities	472.2M	486.7M	510.7M	595.9M	602.8M	669.3M	688.9M	725.5M	1.1B	1.1B
Shareholders' equity	151.2M	185M	216M	188.2M	238.5M	262.4M	282.5M	256.6M	285.7M	385.5M
Total debt	313.1M	312.4M	326.2M	410.7M	426.7M	470.5M	510M	525.5M	761.6M	788.8M
Net debt	257.1M	283.2M	268.6M	374.4M	376.5M	396.2M	468.7M	454.8M	693.5M	727.3M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	91.2M	92.5M	98.7M	114.6M	89.8M	67.1M	70.4M	77M	85.3M	74.5M	77.5M	82M
Receivables	149.2M	150.6M	161.1M	169.5M	160.8M	191.8M	197.5M	228M	217.9M	215.9M	221.5M	238.8M
Inventory	279.2M	286.7M	282.3M	265.9M	272.6M	427.2M	448.4M	444.4M	471.8M	517.3M	539.7M	534.9M
Total current assets	584.4M	586.6M	597.2M	601M	570.8M	746.2M	776M	810.6M	835.8M	862.2M	894.1M	935.5M
Property, plant & equipment	229.7M	239M	239.2M	120.7M	243.9M	375M	378.3M	220.1M	394.9M	394.8M	408.5M	224.6M
Goodwill & intangibles	210.9M	211.3M	205.8M	199.2M	195M	188.9M	184.7M	192.2M	189.3M	185.8M	183.1M	180.2M
Total assets	964.5M	972.7M	979M	982.2M	966.3M	1.3B	1.3B	1.4B	1.4B	1.4B	1.4B	1.5B
Accounts payable	77.2M	86.4M	82.6M	85.6M	86.5M	99.4M	131.6M	138.2M	130.6M	133.3M	129.6M	127.3M
Short-term debt	30.6M	33M	36.9M	37.3M	15.4M	24.3M	25.2M	25.4M	27.5M	29.6M	32.3M	35.6M
Total current liabilities	172.4M	187.7M	189.1M	204.1M	176.9M	233.3M	266.5M	293.5M	270.1M	282.4M	281.9M	316.5M
Long-term debt	487.7M	480M	486.1M	488.2M	496.5M	765.2M	744.8M	736.2M	757.6M	743.6M	755.2M	753.2M
Total liabilities	691.5M	701.9M	708.9M	725.5M	707.8M	1B	1.1B	1.1B	1.1B	1.1B	1.1B	1.1B
Shareholders' equity	273.1M	270.8M	270.1M	256.6M	258.5M	246.8M	266M	285.7M	311.7M	332.4M	361.8M	385.5M
Total debt	518.3M	513.1M	523M	525.5M	511.9M	789.5M	770M	761.6M	785.1M	773.2M	787.4M	788.8M
Net debt	475.2M	480.1M	472.8M	454.8M	460M	722.4M	709.7M	693.5M	712.3M	717.7M	732.5M	727.3M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	64.6M	64.9M	54.7M	33.6M	54.4M	49.2M	32.6M	2.4M	48.3M	99.7M
Depreciation & amortization	26M	26.9M	27.6M	32.3M	31.9M	32.7M	34M	36.2M	45.6M	51.5M
Stock-based compensation	0	334K	2.3M	2.3M	1.1M	0	0	475K	717K	1.6M
Change in working capital	-6.5M	-33.9M	-40.3M	-7.3M	-31.1M	-47.8M	-35.4M	20.9M	-68.7M	-121.4M
Operating cash flow	88M	70.6M	44.7M	68.3M	56.8M	34.5M	29.5M	51.6M	80.1M	69M
Capital expenditure	—	—	—	—	—	—	—	—	-38.3M	-59.1M
Investing cash flow	-1.1M	-66.1M	15.8M	-86.3M	10.7M	14.5M	-22.2M	-7M	-288.7M	-71.5M
Dividends paid	-15.8M	-16.1M	-18.6M	-19.4M	-19.4M	-19.4M	-19.4M	-19.4M	-19.4M	-19.5M
Share repurchases	—	—	—	—	—	—	—	—	—	—
Financing cash flow	-57.7M	-6.8M	21.9M	113.9M	-91M	66.3M	27M	-6.8M	207.1M	-6.6M
Net change in cash	29.2M	-2.2M	82.3M	95.9M	-23.4M	115.3M	34.2M	37.9M	-1.4M	-9.1M
Free cash flow	77.5M	51.5M	17.3M	25.3M	19M	-5.4M	-38.5M	46.4M	41.8M	9.9M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	-8M	1.3M	8.4M	752K	7M	3.2M	20.9M	17.2M	26.5M	27.5M	24M	21.7M
Depreciation & amortization	8.9M	8.9M	9.2M	9.2M	9M	11.6M	12.6M	12.4M	12.8M	12.9M	12.4M	13.3M
Stock-based compensation	81K	80K	135K	179K	179K	180K	179K	179K	339K	434K	411K	413K
Change in working capital	8.9M	11.2M	-10.8M	11.6M	5.5M	-42.5M	8.6M	-40.4M	-19.9M	-36.1M	-27.1M	-38.4M
Operating cash flow	8.4M	24M	9M	10.3M	16.7M	-33.6M	43.7M	21.3M	9.3M	19.4M	16.2M	24.1M
Capital expenditure	—	—	—	—	—	—	—	-13.1M	-13.8M	-11.1M	-15.3M	-18.9M
Investing cash flow	-7.9M	-10.6M	10.9M	4M	6.7M	38.2M	-10.5M	-7M	-21M	-17.2M	-16.8M	-16.5M
Dividends paid	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M	-4.9M
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	1.3M	-14.7M	4.9M	1.8M	-29.2M	276.3M	-32.2M	-7.8M	16.3M	-19M	-2.3M	-1.6M
Net change in cash	1.8M	-1.3M	24.7M	16M	-5.9M	280.9M	964K	6.5M	4.6M	-16.8M	-2.9M	6M
Free cash flow	8.7M	20.6M	1.7M	15.4M	3M	-4.7M	35.4M	8.1M	-4.5M	8.3M	890K	5.2M

Phibro Animal Health Corporation Class A Common Stock Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement